Science & Enterprise subscription

Follow us on Twitter

  • Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were high… https://t.co/oLdLmHGz1M
    about 18 hours ago
  • New post on Science and Enterprise: Venture Funds, Mergers in A.I. Up Sharply in 2018 https://t.co/rimak87tjS #Science #Business
    about 19 hours ago
  • Wish it weren't needed, but ... https://t.co/SZAb2GO2vz
    about 3 days ago
  • The Edelman public relations agency released results of a survey earlier this month gauging the public's awareness… https://t.co/XaxxGJOYQl
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Public, Tech Execs Differ on A.I. Use https://t.co/cvVj3IyCR0 #Science #Business
    about 3 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Company to Stop Cancer Spread, Relapse Raises $60.8M

Cancer magnified

A new company formed to commercialize research that aims to prevent cancer from spreading or recurring is raising $60.75 million in its first venture financing. . . . → Read More: Company to Stop Cancer Spread, Relapse Raises $60.8M

Venture Fund Formed to Back Longevity Research

Older hands on keyboard

A new venture capital fund is being formed to finance start-up companies developing technologies that aim to extend healthy human life spans. . . . → Read More: Venture Fund Formed to Back Longevity Research

Infographic – Apple Phone Sales Down, Wearables Up

Apple earnings Q1 2019

Apple makes more than phones, and while the volume of sales in these other company units is smaller, the percentage gains from last year are healthy. . . . → Read More: Infographic – Apple Phone Sales Down, Wearables Up

Foundation Backs Engineered T-Cells to Treat Lymphoma

T-cells illustration

A new initiative is researching modified immune system cells to treat T-cell lymphoma, a type of blood-related cancer, with a simpler, lower-cost process. . . . → Read More: Foundation Backs Engineered T-Cells to Treat Lymphoma

RNA Therapy Studied for Parkinson’s Side Effects

Kathy Steece-Collier

Medical researchers are developing a treatment for a frequent side-effect of Parkinson’s disease drugs using a corrective RNA molecule to reverse the condition. . . . → Read More: RNA Therapy Studied for Parkinson’s Side Effects

Start-Ups Saying No Thanks to Venture Capital

Calculator cash calendar

Yesterday, we reported on 2018 being a banner year for venture capital, but the New York Times says a movement of entrepreneurs is looking for other ways to raise money. . . . → Read More: Start-Ups Saying No Thanks to Venture Capital

Infographic – Venture Finance Reaching Dot-Com Levels

Venture capital by year

Venture funding last year totaled $99.5 billion, the largest annual outlay since 2000. . . . → Read More: Infographic – Venture Finance Reaching Dot-Com Levels

Spin-Off Gains Seed Funds for Non-Opioid Pain Drug

Molly Shoichet

A company spun-off from a university medical materials lab received start-up funds to develop a non-opioid surgical pain therapy, including a clinical trial. . . . → Read More: Spin-Off Gains Seed Funds for Non-Opioid Pain Drug

Start-up Funds Univ. Medical Cannabis Research

Cannabis plant

A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London. . . . → Read More: Start-up Funds Univ. Medical Cannabis Research

Lilly Buys Precision Cancer Company in $8B Deal

DNA illustration

Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body. . . . → Read More: Lilly Buys Precision Cancer Company in $8B Deal